I. I. Tableau, Exemple d'identification des protéines EBV et de leurs fonctions, Monographie IARC

. Bibliographie,

M. Abdel-hamid, J. J. Chen, N. Constantine, M. Massoud, and N. Raab-traub, EBV Strain Variation: Geographical Distribution and Relation to Disease State, Virology, vol.190, issue.1, pp.168-75, 1992.

J. Agopian, J. Navarro, A. Gac, Y. Lecluse, M. Briand et al., Agricultural Pesticide Exposure and the Molecular Connection to Lymphomagenesis, The Journal of Experimental Medicine, vol.206, issue.7, pp.1473-83, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00408462

C. Aitken, S. K. Sengupta, C. Aedes, D. J. Moss, and T. B. Sculley, Heterogeneity within the Epstein-Barr Virus Nuclear Antigen 2 Gene in Different Strains of EpsteinBarr Virus, The Journal of General Virology, vol.75, pp.95-100, 1994.

M. Altmann, D. Pich, R. Ruiss, J. Wang, B. Sugden et al., Transcriptional Activation by EBV Nuclear Antigen 1 Is Essential for the Expression of EBV's Transforming Genes, Proceedings of the National Academy of Sciences of the United States of America, vol.103, pp.14188-93, 2006.

M. Altun, A. Fandi, O. Dupuis, E. Cvitkovic, Z. Krajina et al., Undifferentiated Nasopharyngeal Cancer (UCNT): Current Diagnostic and Therapeutic Aspects, International Journal of Radiation Oncology*Biology*Physics, vol.32, issue.3, pp.859-77, 1995.

, ANABIBLE-Lymphome de Burkitt, 2016.

R. Baer, A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell et al., DNA Sequence and Expression of the B95-8 Epstein-Barr Virus Genome, Nature, vol.310, issue.5974, pp.207-218, 1984.

R. C. Bargou, F. Emmerich, D. Krappmann, K. Bommert, M. Y. Mapara et al., Constitutive Nuclear Factor-kappaB-RelA Activation Is Required for Proliferation and Survival of Hodgkin's Disease Tumor Cells, The Journal of Clinical Investigation, vol.100, issue.12, pp.2961-69, 1997.

K. W. Beagley and C. M. Gockel, Regulation of Innate and Adaptive Immunity by the Female Sex Hormones Oestradiol and Progesterone, FEMS Immunology and Medical Microbiology, vol.38, issue.1, pp.13-22, 2003.

M. Benkerrou, J. Jais, V. Leblond, A. Durandy, L. Sutton et al., Anti-B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome, Blood, vol.92, issue.9, pp.3137-3184, 1998.

S. Bertrand, R. Berger, T. Philip, A. Bernheim, P. A. Bryon et al., Variant Translocation in a Non Endemic Case of Burkitt's Lymphoma: T (8;22) in an Epstein-Barr Virus Negative Tumour and in a Derived Cell Line, European Journal of Cancer, vol.17, issue.5, pp.577-84, 1981.

J. Blay, Les Cibles Membranaires de La Cellule Tumorale : 1ère Partie, 2010.

A. Bochkarev, J. A. Barwell, R. A. Pfuetzner, W. Furey, M. Aled et al., Crystal Structure of the DNA-Binding Domain of the Epstein-Barr Virus Origin-Binding Protein EBNA1, Cell, vol.83, issue.1, pp.39-46, 1995.

J. N. Bouwes-bavinck, D. R. Hardie, A. Green, S. Cutmore, A. Macnaught et al., The Risk of Skin Cancer in Renal Transplant Recipients in Queensland, Australia. A Follow-up Study, Transplantation, vol.61, issue.5, pp.715-736, 1996.

B. Brennan, Nasopharyngeal Carcinoma, Orphanet Journal of Rare Diseases, vol.1, p.23, 2006.

P. Brice and D. Sénécal, Le lymphome hodgkinien, 2013.

P. Brousset, D. Schlaifer, F. Meggetto, E. Bachmann, S. Rothenberger et al., Persistence of the Same Viral Strain in Early and Late Relapses of Epstein-Barr Virus-Associated Hodgkin's Disease, Blood, vol.84, issue.8, pp.2447-51, 1994.

. Burcheri, . Donadio, . Garrido, . Legouffe, . Quinquenet et al., Référentiel Régional Onco-LR, Lymphome de Burkitt, 2013.

R. D. Burt, L. Thomas, B. Vaughan, and . Mcknight, Descriptive Epidemiology and Survival Analysis of Nasopharyngeal Carcinoma in the United States, International Journal of Cancer, vol.52, issue.4, pp.549-56, 1992.

J. Cai and P. I. Terasaki, Human Leukocyte Antigen Antibodies for Monitoring Transplant Patients, Surgery Today, vol.35, issue.8, pp.605-617, 2005.

. Campo, S. H. Elias, N. L. Swerdlow, S. Harris, H. Pileri et al., The 2008 WHO Classification of Lymphoid Neoplasms and beyond: Evolving Concepts and Practical Applications, Blood, vol.117, pp.5019-5051, 2011.

P. P. Carbone, H. S. Kaplan, K. Musshoff, D. W. Smithers, and M. Tubiana, Report of the Committee on Hodgkin's Disease Staging Classification, Cancer Research, vol.31, issue.11, pp.1860-61, 1971.

A. Carracedo and P. P. Pandolfi, The PTEN-PI3K Pathway: Of Feedbacks and Cross-Talks, 2015. DocCheck Pictures. Accessed, vol.27, pp.5527-5568, 2008.

C. Cayrol and E. Flemington, The Epstein-Barr Virus bZIP Transcription Factor Zta Causes G0/G1 Cell Cycle Arrest through Induction of Cyclin-Dependent Kinase Inhibitors, The EMBO Journal, vol.15, issue.11, pp.2748-59, 1996.

A. Chadburn, N. Suciu-foca, E. Cesarman, E. Reed, R. E. Michler et al., Post-Transplantation Lymphoproliferative Disorders Arising in Solid Organ Transplant Recipients Are Usually of Recipient Origin, The American Journal of Pathology, vol.147, issue.6, pp.1862-70, 1995.

D. Chellapandian, R. Das, K. Zelley, S. J. Wiener, H. Zhao et al., Treatment of Epstein Barr VirusInduced Haemophagocytic Lymphohistiocytosis with Rituximab-Containing ChemoImmunotherapeutic Regimens, British Journal of Haematology, vol.162, issue.3, pp.376-82, 2013.

W. K. Chia, W. Wang, M. Teo, W. M. Tai, W. T. Lim et al., A Phase II Study Evaluating the Safety and Efficacy of an Adenovirus?LMP1-LMP2 Transduced Dendritic Cell Vaccine in Patients with Advanced Metastatic Nasopharyngeal Carcinoma, Annals of Oncology, vol.23, issue.4, pp.997-1005, 2012.

J. I. Cohen, F. Wang, J. Mannick, and E. Kieff, Epstein-Barr Virus Nuclear Protein 2 Is a Key Determinant of Lymphocyte Transformation, Proceedings of the National Academy of Sciences, vol.86, issue.23, pp.9558-62, 1989.

J. I. Cohen, Epstein-Barr Virus Infection, New England Journal of Medicine, vol.343, issue.7, pp.481-92, 2000.

J. I. Cohen, Epstein-barr Virus Vaccines, Clinical & Translational Immunology, vol.4, issue.1, p.32, 2015.

J. I. Cohen and K. Lekstrom, Epstein-Barr Virus BARF1 Protein Is Dispensable for B-Cell Transformation and Inhibits Alpha Interferon Secretion from Mononuclear Cells, Journal of Virology, vol.73, issue.9, pp.7627-7659, 1999.

S. A. Connolly, J. O. Jackson, T. S. Jardetzky, and R. Longnecker, Fusing Structure and Function: A Structural View of the Herpesvirus Entry Machinery, Nature Reviews Microbiology, vol.9, issue.5, pp.369-81, 2011.

R. Correa, . Mariel, D. María, L. V. Fellner, K. Alonio et al., Epstein-Barr Virus (EBV) in Healthy Carriers: Distribution of Genotypes and 30 Bp Deletion in Latent Membrane Protein-1 (LMP-1) Oncogene, Journal of Medical Virology, vol.73, issue.4, pp.583-88, 2004.

C. Cracco, M. Divine, and B. Maitre, Atteintes Thoraciques Au Cours Des Lymphomes Hodgkiniens, Revue Des Maladies Respiratoires, vol.24, issue.8, pp.999-1012, 2007.

C. M. Cserti-gazdewich, K. Thomas, L. G. Waddell, C. Singer, J. M. Chaparro et al., Passenger Lymphocyte Syndrome with or without Immune Hemolytic Anemia in All Rh-Positive Recipients of Lungs from Rhesus Alloimmunized Donors: Three New Cases and a Review of the Literature, Transfusion Medicine Reviews, vol.23, issue.2, pp.134-179, 2009.

S. Degeorges, A. Mesnil, A. Marion-audibert, F. Bouafia-sauvy, F. Berger et al., Manifestations anorectales, en rapport avec un lymphome de Burkitt associé au virus Epstein Barr, chez une malade immunocompétente, 2008.

D. B. Duggan, R. Gina, J. L. Petroni, J. H. Johnson, R. I. Glick et al., Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin's Disease: Report of an Intergroup Trial, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.21, issue.4, pp.607-621, 2003.

J. M. Edwards and M. Woodroof, EB Virus-Specific IgA in Serum of Patients with Infectious Mononucleosis and of Healthy People of Different Ages, Journal of Clinical Pathology, vol.32, issue.10, pp.1036-1076, 1979.

M. A. Epstein, B. Achong, and Y. Barr, VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA, vol.283, pp.702-705, 1964.

, Epstein-Barr Virus in Systemic Autoimmune Diseases, 2016.

A. Eskild, A. Bruu, B. Stray-pedersen, and P. Jenum, Epstein-Barr Virus Infection during Pregnancy and the Risk of Adverse Pregnancy Outcome, BJOG: An International Journal of Obstetrics and Gynaecology, vol.112, issue.12, pp.1620-1644, 2005.

. Fafi-kremer, P. Samira, J. Morand, P. Brion, M. Pavese et al., Long-Term Shedding of Infectious Epstein-Barr Virus after Infectious Mononucleosis, The Journal of Infectious Diseases, vol.191, issue.6, pp.985-89, 2005.

D. V. Faller, S. J. Mentzer, and S. P. Perrine, Induction of the Epstein-Barr Virus Thymidine Kinase Gene with Concomitant Nucleoside Antivirals as a Therapeutic Strategy for Epstein-Barr Virus-Associated Malignancies, Current Opinion in Oncology, vol.13, issue.5, pp.360-67, 2001.

E. Flemington and S. Speck, Epstein-Barr Virus BZLF1 Trans Activator Induces the Promoter of a Cellular Cognate Gene, c-Fos, Journal of Virology, vol.64, issue.9, pp.4549-52, 1990.

R. L. Foote, C. Loprinzi, A. Frank, J. R-o'fallon, H. Gulavita et al., Randomized Trial of a Chlorhexidine Mouthwash for Alleviation of Radiation-Induced Mucositis, Journal of Clinical Oncology, vol.12, issue.12, pp.2630-2663, 1994.

D. Forman, F. Bray, D. H. Brewster, C. G. Mbalawa, B. Kohler et al., Cancer Incidence in Five Continents, 2014.

D. Frank, E. Cesarman, Y. F. Liu, R. E. Michler, and D. M. Knowles, Posttransplantation Lymphoproliferative Disorders Frequently Contain Type A and Not Type B Epstein-Barr Virus, Blood, vol.85, issue.5, pp.1396-1403, 1995.

S. Fujita, N. Buziba, A. Kumatori, M. Senba, A. Yamaguchi et al., Early Stage of Epstein-Barr Virus Lytic Infection Leading to The 'starry Sky' pattern Formation in Endemic Burkitt Lymphoma, Archives of Pathology & Laboratory Medicine, vol.128, issue.5, pp.549-52, 2004.

D. P. Funch, A. M. Walker, G. Schneider, N. J. Ziyadeh, and M. D. Pescovitz, Ganciclovir and Acyclovir Reduce the Risk of Post-Transplant Lymphoproliferative Disorder in Renal Transplant Recipients, American Journal of Transplantation, vol.5, issue.12, pp.2894-2900, 2005.

M. K. Gandhi, J. T. Tellam, and R. Khanna, Epstein-Barr Virus-Associated Hodgkin's Lymphoma, British Journal of Haematology, vol.125, issue.3, pp.267-81, 2004.

, Généralités Sur Les Virus, 2016.

R. Germi, M. Baccard, J. Seigneurin, and P. Morand, Infections à virus EpsteinBarr, EMC-Maladies infectieuses, vol.8, pp.50125-50130, 2011.

E. Gershburg and J. S. Pagano, Epstein-Barr Virus Infections: Prospects for Treatment, Journal of Antimicrobial Chemotherapy, vol.56, issue.2, pp.277-81, 2005.

P. Girard, C. Katlama, and G. Pialoux, , 2007.

S. L. Glaser, R. J. Lin, S. L. Stewart, R. F. Ambinder, R. F. Jarrett et al., Epstein-Barr Virus-Associated Hodgkin's Disease: Epidemiologic Characteristics in International Data, International Journal of Cancer. Journal International Du Cancer, vol.70, issue.4, pp.375-82, 1997.

W. L. Goldschmidts, K. Bhatia, J. F. Johnson, N. Akar, M. I. Gutiérrez et al., Epstein-Barr Virus Genotypes in AIDSAssociated Lymphomas Are Similar to Those in Endemic Burkitt's Lymphomas, Leukemia, vol.6, issue.9, pp.875-78, 1992.

J. W. Gratama and I. Ernberg, Molecular Epidemiology of Epstein-Barr Virus Infection, Advances in Cancer Research, vol.67, pp.197-255, 1995.

A. Greco, J. Diaz, D. Thouvenot, and F. Morfin, Novel Targets for the Development of Anti-Herpes Compounds, Infectious Disorders Drug Targets, vol.7, issue.1, pp.11-18, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00179468

B. E. Griffin and L. Karran, Immortalization of Monkey Epithelial Cells by Specific Fragments of Epstein-Barr Virus DNA, Nature, vol.309, issue.5963, pp.78-82, 1983.

C. Guettier, Les Proliférations Lymphoides Après Transplantation D'organe, In Annales de Pathologie, vol.12, pp.85-97, 1992.

D. E. Gutsch, E. Holley-guthrie, . Zhang, M. Stein, A. Blanar et al., The bZIP Transactivator of Epstein-Barr Virus, BZLF1, Functionally and Physically Interacts with the p65 Subunit of NF-Kappa B, Molecular and Cellular Biology, vol.14, issue.3, pp.1939-1987, 1994.

W. Hammerschmidt and B. Sugden, Identification and Characterization of oriLyt, a Lytic Origin of DNA Replication of Epstein-Barr Virus, Cell, vol.55, issue.3, pp.427-460, 1988.

J. Hebting and G. Ferrand, Chapitre 10-Cancers Des Voies Aérodigestives Supérieures, Kinésithérapie de La Face, pp.99-117, 2015.

G. Henle, V. Henle, and . Diehl, Relation of Burkitt's Tumor-Associated HerpesYtpe Virus to Infectious Mononucleosis, Proceedings of the National Academy of Sciences of the United States of America, vol.59, issue.1, pp.94-101, 1968.

H. E. Heslop, How I Treat EBV Lymphoproliferation, Blood, vol.114, pp.4002-4010, 2009.

A. Hildesheim, R. J. Apple, C. Chen, S. S. Wang, Y. Cheng et al., Association of HLA Class I and II Alleles and Extended Haplotypes with Nasopharyngeal Carcinoma in Taiwan, Journal of the National Cancer Institute, vol.94, issue.23, pp.1780-89, 2002.

. Hodgkin, On Some Morbid Appearances of the Absorbent Glands and Spleen, Medico-Chirurgical Transactions, vol.17, pp.68-114

S. Houalef, Cavum Imagerie, 2015.

L. F. Hu, E. R. Zabarovsky, F. Chen, S. L. Cao, I. Ernberg et al., , 1991.

C. Nasopharyngeal and C. , The Journal of General Virology, vol.72, pp.2399-2409

E. P. Hui, S. Graham, H. Taylor, B. B. Jia, S. L. Ma et al., Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients, Cancer Research, vol.73, issue.6, pp.1676-88, 2013.

, Human Herpesvirus 4 Gene for EBER 1 Small RNA, Complete Sequence, 2001.

S. Hung, M. Chun, E. Kang, and . Kieff, Maintenance of Epstein-Barr Virus (EBV) oriP-Based Episomes Requires EBV-Encoded Nuclear Antigen-1, 2001.

, Which Can Be Replaced by High-Mobility Group-I or Histone H1, Chromosome-Binding Domains, vol.98, pp.1865-70, 2016.

, International Committee on Taxonomy of Viruses, 2016.

F. Islami, A. Pourshams, D. Nasrollahzadeh, F. Kamangar, S. Fahimi et al., Tea Drinking Habits and Oesophageal Cancer in a High Risk Area in Northern Iran: Population Based CaseControl Study, BMJ, vol.338, p.929, 2009.

D. Jeannel, A. Hubert, F. De-vathaire, R. Ellouz, M. Camoun et al., Diet, Living Conditions and Nasopharyngeal Carcinoma in Tunisia-a Case-Control Study, International Journal of Cancer, vol.46, issue.3, pp.421-446, 1990.

X. Jiang and X. Wang, Cytochrome c Promotes Caspase-9 Activation by Inducing Nucleotide Binding to Apaf-1, Journal of Biological Chemistry, vol.275, issue.40, pp.31199-203, 2000.

S. Joos, M. Küpper, S. Ohl, G. Frederike-von-bonin, M. Mechtersheimer et al., Genomic Imbalances Including Amplification of the Tyrosine Kinase Gene JAK2 in CD30+ Hodgkin Cells, Cancer Research, vol.60, issue.3, pp.549-52, 2000.

F. Juillard, E. Hiriart, N. Sergeant, V. Vingtdeux-didier, and H. Drobecq, Epstein-Barr Virus Protein EB2 Contains an N-Terminal Transferable Nuclear Export Signal That Promotes Nucleocytoplasmic Export by Directly Binding TAP/NXF1, Journal of Virology, vol.83, issue.24, pp.12759-68, 2009.

B. Kaiser-mccaw, A. L. Epstein, H. S. Kaplan, and F. Hecht, Chromosome 14 Translocation in African and North American Burkitt's Lymphoma, International Journal of Cancer. Journal International Du Cancer, vol.19, issue.4, pp.482-86, 1977.

M. A. Kaplan, J. A. Ferry, N. L. Harris, and J. O. Jacobson, Clonal Analysis of Posttransplant Lymphoproliferative Disorders, Using Both Episomal Epstein-Barr Virus and Immunoglobulin Genes as Markers, American Journal of Clinical Pathology, vol.101, issue.5, pp.590-96, 1994.

H. Kashkar, C. Haefs, H. Shin, J. Stephen, G. S. Hamilton-dutoit et al., XIAP-Mediated Caspase Inhibition in Hodgkin's Lymphoma-Derived B Cells, The Journal of Experimental Medicine, vol.198, issue.2, pp.341-388, 2003.

M. Kato, M. Sanada, I. Kato, Y. Sato, J. Takita et al., Frequent Inactivation of A20 in B-Cell Lymphomas, Nature, vol.459, issue.7247, pp.712-728, 2009.

M. Katoh and M. Katoh, Identification and Characterization of JMJD2 Family Genes in Silico, International Journal of Oncology, vol.24, issue.6, pp.1623-1651, 2004.

S. C. Kenney, Reactivation and Lytic Replication of EBV, Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, 2007.

I. Kim, E. Park, S. Park, Z. Lin, and Y. Kim, Characteristics of Epstein-Barr Virus Isolated from the Malignant Lymphomas in Korea, Journal of Medical Virology, vol.67, issue.1, pp.59-66, 2002.

H. Kimura, Y. Hoshino, H. Kanegane, I. Tsuge, T. Okamura et al., Clinical and Virologic Characteristics of Chronic Active Epstein-Barr Virus Infection, Blood, vol.98, issue.2, pp.280-86, 2001.

C. Klumb, R. Esteves, D. Hassan, L. Oliveira, M. K. Maria-magalhães-de-resende et al., Geographic Variation in Epstein-Barr Virus-Associated Burkitt's Lymphoma in Children from Brazil, International Journal of Cancer. Journal International Du Cancer, vol.108, issue.1, 2004.

O. I. Kubrak, V. Viktor, . Husak, M. Bohdana, H. Rovenko et al., Tissue Specificity in Nickel Uptake and Induction of Oxidative Stress in Kidney and Spleen of Goldfish Carassius Auratus, Exposed to Waterborne Nickel, Aquatic Toxicology, pp.88-96, 2012.

M. Kunimoto, S. Tamura, T. Tabata, and O. Yoshie, One-Step Typing of Epstein-Barr Virus by Polymerase Chain Reaction: Predominance of Type 1 Virus in Japan, The Journal of General Virology, vol.73, issue.2, pp.455-61, 1992.

R. Küppers, The Biology of Hodgkin's Lymphoma, Nature Reviews. Cancer, vol.9, issue.1, pp.15-27, 2009.

R. Küppers, A. Engert, and M. Hansmann, Hodgkin Lymphoma, The Journal of Clinical Investigation, vol.122, issue.10, pp.3439-3486, 2012.

M. T. Kyaw, L. Hurren, L. Evans, D. J. Moss, D. A. Cooper et al., Expression of B-Type Epstein-Barr Virus in HIV-Infected Patients and Cardiac Transplant Recipients, AIDS Research and Human Retroviruses, vol.8, issue.11, pp.1869-74, 1992.

, Laboratoire d'Hématologie Cellulaire Du CHU d'Angers, 2016.

S. Laouamri, M. Hamdi-cherif, N. Sekfali, L. Mokhtari, and R. Kharchi, Facteurs de risque alimentaires du carcinome du nasopharynx dans la région de Sétif (Algérie), vol.49, pp.145-56, 2001.

B. K. Law, Rapamycin: An Anti-Cancer Immunosuppressant?, Critical Reviews in Oncology/Hematology, vol.56, issue.1, pp.47-60, 2005.

L. Clorennec, C. , T. Ouk, I. Youlyouz-marfak, S. Panteix et al., Molecular Basis of Cytotoxicity of Epstein-Barr Virus (EBV) Latent Membrane Protein 1 (LMP1) in EBV Latency III B Cells: LMP1 Induces Type II Ligand-Independent Autoactivation of CD95/Fas with Caspase 8-Mediated Apoptosis, Journal of Virology, vol.82, issue.13, pp.6721-6754, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00451206

V. Leblond, L. Sutton, R. Dorent, F. Davi, M. O. Bitker et al., Lymphoproliferative Disorders after Organ Transplantation: A Report of 24 Cases Observed in a Single Center, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.13, issue.4, pp.961-68, 1995.

T. Lelo, . Mp, K. Malenga, E. Ndoma, and . Bielelie, Le Lymphome de Burkitt À Localisation Maxillo-Faciale. Aspects Radiologiques, Médecine D'Afrique Noire, 1992.

, Les Chiffres Clés-Don D'organes-Agence de La Biomédecine, 2016.

P. H. Levine, D. V. Ablashi, C. W. Berard, P. P. Carbone, D. E. Waggoner et al., Elevated Antibody Titers to Epstein-Barr Virus in Hodgkin's Disease, Cancer, vol.27, issue.2, pp.416-437, 1971.

Q. Li, M. Spriggs, S. Kovats, M. Turk, . Comeau et al., Epstein-Barr Virus Uses HLA Class II as a Cofactor for Infection of B Lymphocytes, Journal of Virology, vol.71, issue.6, pp.4657-62, 1997.

X. Li, R. Fasano, E. Wang, K. Yao, and F. M. Marincola, HLA Associations with Nasopharyngeal Carcinoma, Current Molecular Medicine, vol.9, issue.6, pp.751-65, 2009.

X. Li, N. Ghandri, D. Piancatelli, S. Adams, D. Chen et al., Associations between HLA Class I Alleles and the Prevalence of Nasopharyngeal Carcinoma (NPC) among Tunisians, Journal of Translational Medicine, vol.5, p.22, 2007.

C. Lin, W. Lo, T. Lee, Y. Ren, S. Hwang et al., Immunization with Epstein-Barr Virus (EBV) PeptidePulsed Dendritic Cells Induces Functional CD8+ T-Cell Immunity and May Lead to Tumor Regression in Patients with EBV-Positive Nasopharyngeal Carcinoma, Cancer Research, vol.62, issue.23, pp.6952-58, 2002.

A. F. List, F. A. Greco, and L. B. Vogler, Lymphoproliferative Diseases in Immunocompromised Hosts: The Role of Epstein-Barr Virus, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.5, issue.10, pp.1673-89, 1987.

J. Locker and M. Nalesnik, Molecular Genetic Analysis of Lymphoid Tumors Arising after Organ Transplantation, The American Journal of Pathology, vol.135, issue.6, pp.977-87, 1989.

L. Y. Bonobo, Burkitt's-Disturbing Images, 2008.

K. Luzuriaga and J. L. Sullivan, Infectious Mononucleosis, New England Journal of Medicine, vol.362, issue.21, pp.1993-2000, 2010.

I. Magrath, Epidemiology: Clues to the Pathogenesis of Burkitt Lymphoma: Review, British Journal of Haematology, vol.156, issue.6, pp.744-56, 2012.

J. B. Mannick, J. I. Cohen, M. Birkenbach, A. Marchini, and E. Kieff, The EpsteinBarr Virus Nuclear Protein Encoded by the Leader of the EBNA RNAs Is Important in B-Lymphocyte Transformation, Journal of Virology, vol.65, issue.12, pp.6826-6863, 1991.

T. Marafioti, M. Hummel, H. D. Foss, H. Laumen, P. Korbjuhn et al., Hodgkin and Reed-Sternberg Cells Represent an Expansion of a Single Clone Originating from a Germinal Center B-Cell with Functional Immunoglobulin Gene Rearrangements but Defective Immunoglobulin Transcription, Blood, vol.95, issue.4, pp.1443-50, 2000.

R. Marks and J. Finke, Biologics in the Prevention and Treatment of Graft Rejection, Springer Seminars in Immunopathology, vol.27, issue.4, pp.457-76, 2006.

J. I. Martín-subero, S. Gesk, L. Harder, T. Sonoki, P. W. Tucker et al., Recurrent Involvement of the REL and BCL11A Loci in Classical Hodgkin Lymphoma, Blood, vol.99, issue.4, pp.1474-77, 2002.

S. Maruo, E. Johannsen, D. Illanes, A. Cooper, B. Zhao et al., Epstein-Barr Virus Nuclear Protein 3A Domains Essential for Growth of Lymphoblasts: Transcriptional Regulation through RBP-Jkappa/CBF1 Is Critical, Journal of Virology, vol.79, issue.16, pp.10171-79, 2005.

S. Maruo, Y. Wu, S. Ishikawa, T. Kanda, D. Iwakiri et al., Epstein-Barr Virus Nuclear Protein EBNA3C Is Required for Cell Cycle Progression and Growth Maintenance of Lymphoblastoid Cells, Proceedings of the National Academy of Sciences, vol.103, issue.51, pp.19500-505, 2006.

S. M. Mbulaiteye, J. Robert, K. Biggar, M. S. Bhatia, S. S. Linet et al., Sporadic Childhood Burkitt Lymphoma Incidence in the United States during 1992-2005, Pediatric Blood & Cancer, vol.53, issue.3, pp.366-70, 2009.
DOI : 10.1002/pbc.22047

URL : http://europepmc.org/articles/pmc2713377?pdf=render

W. E. Miller, G. Mosialos, E. Kieff, and N. Raab-traub, Epstein-Barr Virus LMP1 Induction of the Epidermal Growth Factor Receptor Is Mediated through a TRAF Signaling Pathway Distinct from NF-kappaB Activation, Journal of Virology, vol.71, issue.1, pp.586-94, 1997.

P. Moreau, J. L. Harousseau, J. Wijdenes, N. Morineau, N. Milpied et al., A Combination of Anti-Interleukin 6 Murine Monoclonal Antibody with Dexamethasone and High-Dose Melphalan Induces High Complete Response Rates in Advanced Multiple Myeloma, British Journal of Haematology, vol.109, issue.3, pp.661-64, 2000.

J. A. Morrison and N. Raab-traub, Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of {beta}-Catenin Signaling, Journal of Virology, vol.79, issue.4, pp.2375-82, 2005.

G. Mosialos, M. Birkenbach, R. Yalamanchili, T. Vanarsdale, C. Ware et al., The Epstein-Barr Virus Transforming Protein LMP1 Engages Signaling Proteins for the Tumor Necrosis Factor Receptor Family, Cell, vol.80, issue.3, pp.389-99, 1995.

M. Moutschen, P. Léonard, E. M. Sokal, F. Smets, M. Haumont et al., Phase I/II Studies to Evaluate Safety and Immunogenicity of a Recombinant gp350 Epstein-Barr Virus Vaccine in Healthy Adults, Vaccine, vol.25, issue.24, pp.4697-4705, 2007.

C. Münz, Current Topics in Microbiology and Immunology, vol.2

S. B. Murphy, Classification, Staging and End Results of Treatment of Childhood Non-Hodgkin's Lymphomas: Dissimilarities from Lymphomas in Adults, Seminars in Oncology, vol.7, issue.3, pp.332-371, 1980.

H. Näher, L. Gissmann, U. K. Freese, D. Petzoldt, and S. Helfrich, Subclinical Epstein-Barr Virus Infection of Both the Male and Female Genital Tract-Indication for Sexual Transmission, The Journal of Investigative Dermatology, vol.98, issue.5, pp.791-93, 1992.

B. Neuhierl, R. Feederle, W. Hammerschmidt, and H. J. Delecluse, Glycoprotein gp110 of Epstein-Barr Virus Determines Viral Tropism and Efficiency of Infection, Proceedings of the National Academy of Sciences, vol.99, issue.23, pp.15036-15077, 2002.

N. , Hodgkin Lymphoma-Diagnosis-NHS Choices, 2016.

K. E. Nichols, J. Hom, . Shun-you, A. Gong, C. S. Ganguly et al.,

. Stein, Regulation of NKT Cell Development by SAP, the Protein Defective in XLP, Nature Medicine, vol.11, issue.3, pp.340-385, 2005.

H. Niller, H. Helmut, J. Wolf, and . Minarovits, Regulation and Dysregulation of Epstein-Barr Virus Latency: Implications for the Development of Autoimmune Diseases, Autoimmunity, vol.41, issue.4, pp.298-328, 2008.

C. Ok, T. G. Young, L. J. Papathomas, K. H. Medeiros, and . Young, EBV-Positive Diffuse Large B-Cell Lymphoma of the Elderly, Blood, vol.122, issue.3, pp.328-368, 2013.

, OMS | Cancer, 2016.

, Oncolor:Carcinomes Nasopharyngés-Oncologik-OncoLogiK, Carcinomes_nasopharyng%C3%A9s#Car cinomes_nasopharyng.C3.A9s_.28NPC.29, 2016.

C. Otto, M. Giefing, A. Massow, I. Vater, S. Gesk et al., Genetic Lesions of the TRAF3 and MAP3K14 Genes in Classical Hodgkin Lymphoma, British Journal of Haematology, vol.157, issue.6, pp.702-710, 2012.

I. Outils, , 2012.

C. Patte, A. Auperin, J. Michon, H. Behrendt, G. Leverger et al., The Société Française d'Oncologie Pédiatrique LMB89 Protocol: Highly Effective Multiagent Chemotherapy Tailored to the Tumor Burden and Initial, p.561, 2001.

, Unselected Children with B-Cell Lymphomas and L3 Leukemia, Blood, vol.97, issue.11, pp.3370-79

C. Patte, T. Philip, C. Rodary, J. M. Zucker, H. Behrendt et al., High Survival Rate in Advanced-Stage B-Cell Lymphomas and Leukemias without CNS Involvement with a Short Intensive Polychemotherapy: Results from the French Pediatric Oncology Society of a Randomized Trial of 216 Children, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.9, issue.1, pp.123-155, 1991.

P. M. Pegman, M. Sinéad, B. N. Smith, S. T. D'souza, S. Loughran et al., Epstein-Barr Virus Nuclear Antigen 2 Trans-Activates the Cellular Antiapoptotic Bfl-1 Gene by a CBF1/RBPJ Kappa-Dependent Pathway, Journal of Virology, vol.80, issue.16, pp.8133-8177, 2006.

I. Penn, Cancers Following Cyclosporine Therapy, Transplantation, vol.43, issue.1, pp.32-35, 1987.

I. Penn, Depressed Immunity and the Development of Cancer, Cancer Detection and Prevention, vol.18, issue.4, pp.241-52, 1994.

I. Penn, Liver Transplantation and Surgery: Official Publication of the American Association for the Study of Liver Diseases and the International Liver, Transplantation Society, vol.2, issue.1, pp.52-59, 1996.

I. Penn and G. Porat, Central Nervous System Lymphomas in Organ Allograft Recipients, Transplantation, vol.59, issue.2, pp.240-284, 1995.

S. Pereira, F. Gaspar, and . Oakley, Nuclear Factor-?B1: Regulation and Function, The International Journal of Biochemistry & Cell Biology, vol.40, issue.8, 2008.

N. D. Perkins and T. D. Gilmore, Good Cop, Bad Cop: The Different Faces of NF?B, Cell Death & Differentiation, vol.13, issue.5, pp.759-72, 2006.

M. E. Peter and P. H. Krammer, The CD95(APO-1/Fas) DISC and beyond, Cell Death and Differentiation, vol.10, issue.1, pp.26-35, 2003.

S. Pillet, Ã?chappement de lâ? TM EBV Au système Immunitaireâ??: gp42â??se Lie Aux molécules CMH de Classe II, Virologie, vol.9, issue.1, pp.69-69, 2005.

T. Powles, G. Matthews, and M. Bower, AIDS Related Systemic Non-Hodgkin's Lymphoma, Sexually Transmitted Infections, vol.76, issue.5, pp.335-376, 2000.

L. M. Prescott, M. Linda, C. J. Sherwood, and . Woolverton, , 2010.

, Processus Tumoraux-Généralités, 2016.

D. T. Purtilo, C. Cassel, and J. P. Yang, Letter: Fatal Infectious Mononucleosis in Familial Lymphohistiocytosis, The New England Journal of Medicine, vol.291, issue.14, 1974.

P. S. Randhawa, R. Jaffe, A. J. Demetris, M. Nalesnik, T. E. Starzl et al., Expression of Epstein-Barr Virus-Encoded Small RNA, 1992.

, Liver Specimens from Transplant Recipients with Post-Transplantation Lymphoproliferative Disease, vol.327, pp.1710-1724

T. D. Rea, J. E. Russo, W. Katon, R. L. Ashley, and D. S. Buchwald, Prospective Study of the Natural History of Infectious Mononucleosis Caused by Epstein-Barr Virus, The Journal of the American Board of Family Practice, vol.14, issue.4, pp.234-276, 2001.

M. P. Rechsteiner, C. Berger, L. Zauner, J. A. Sigrist, M. Weber et al., Latent Membrane Protein 2B Regulates Susceptibility to Induction of Lytic Epstein-Barr Virus Infection, Journal of Virology, vol.82, issue.4, pp.1739-1786, 2008.

J. Ricci, Revues-Apoptose, 2016.

A. B. Rickinson, Chronic, Symptomatic Epstein-Barr Virus Infections, Immunology Today, vol.7, issue.1, pp.13-14, 1986.

C. M. Rooney, S. K. Loftin, M. S. Holladay, M. K. Brenner, R. A. Krance et al., Early Identification of Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease, British Journal of Haematology, vol.89, issue.1, pp.98-103, 1995.

N. Rosdahl, S. O. Larsen, and A. B. Thamdrup, Infectious Mononucleosis in Denmark. Epidemiological Observations Based on Positive Paul-Bunnell Reactions from 1940-1969, Scandinavian Journal of Infectious Diseases, vol.5, issue.3, pp.163-70, 1973.

L. Rui, N. C. Tolga-emre, M. J. Kruhlak, H. Chung, C. Steidl et al., Cooperative Epigenetic Modulation by Cancer Amplicon Genes, Cancer Cell, vol.18, issue.6, pp.590-605, 2010.

A. J. Sadler and B. R. Williams, Structure and Function of the Protein Kinase R, Current Topics in Microbiology and Immunology, vol.316, pp.253-92, 2007.

. Salek-ardakani, J. R. Shahram, M. Arrand, and . Mackett, Epstein-Barr Virus Encoded Interleukin-10 Inhibits HLA-Class I, ICAM-1, and B7 Expression on Human Monocytes: Implications for Immune Evasion by EBV, Virology, vol.304, issue.2, pp.342-51, 2002.

M. Samanta and K. Takada, Modulation of Innate Immunity System by Epstein-Barr Virus-Encoded Non-Coding RNA and Oncogenesis, Cancer Science, vol.101, issue.1, pp.29-35, 2010.

J. Sample, L. Young, B. Martin, T. Chatman, E. Kieff et al., Epstein-Barr Virus Types 1 and 2 Differ in Their EBNA-3A, EBNA-3B, and EBNA3C Genes, Journal of Virology, vol.64, issue.9, pp.4084-92, 1990.

Y. Samuels and K. Ericson, Oncogenic PI3K and Its Role in Cancer, Current Opinion in Oncology, vol.18, issue.1, pp.77-82, 2006.

K. Sandvej, S. C. Peh, B. S. Andresen, and G. Pallesen, Identification of Potential Hot Spots in the Carboxy-Terminal Part of the Epstein-Barr Virus (EBV) BNLF-1 Gene in Both Malignant and Benign EBV-Associated Diseases: High Frequency of a 30-Bp Deletion in Malaysian and Danish Peripheral T-Cell Lymphomas, Blood, vol.84, issue.12, pp.4053-60, 1994.

R. N. Sawyer, A. S. Evans, J. C. Niederman, and R. W. Mccollum, Prospective Studies of a Group of Yale University Freshmen. I. Occurrence of Infectious Mononucleosis, The Journal of Infectious Diseases, vol.123, issue.3, pp.263-70, 1971.

J. Sayos, C. Wu, M. Morra, N. Wang, X. Zhang et al., The X-Linked Lymphoproliferative-Disease Gene Product SAP Regulates Signals Induced through the Co-Receptor SLAM, Nature, vol.395, issue.6701, pp.462-69, 1998.

C. D. Shannon-lowe, B. Neuhierl, G. Baldwin, A. B. Rickinson, and H. Delecluse, Resting B Cells as a Transfer Vehicle for Epstein-Barr Virus Infection of Epithelial Cells, Proceedings of the National Academy of Sciences, vol.103, issue.18, pp.7065-70, 2006.

C. H. Shu, Y. S. Chang, C. L. Liang, S. T. Liu, C. Z. Lin et al., Distribution of Type A and Type B EBV in Normal Individuals and Patients with Head and Neck Carcinomas in Taiwan, Journal of Virological Methods, vol.38, issue.1, pp.123-153, 1992.

, Signs and Symptoms of Hodgkin Disease, 2016.

, Signs and Symptoms of Nasopharyngeal Cancer, Accessed November, vol.8, 2016.

, Sirtin, 2016.

L. H. Sobin and M. K. Gospodarowicz, Ch Wittekind, and International Union against Cancer, 2010.

D. Sommelet, J. Clavel, and B. Lacour, Epidémiologie des cancers de l'enfant, 2009.

T. Splettstoesser, Capside icosahédrique d'un adénovirus, 2016.

T. P. Spunt and F. A. Evans, Mononuclear Leucocytosis in Reaction to Acute Infections, 1920.

S. Sriamporn, V. Vatanasapt, P. Pisani, S. Yongchaiyudha, and V. Rungpitarangsri, Environmental Risk Factors for Nasopharyngeal Carcinoma: A Case-Control Study in Northeastern Thailand, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, vol.1, issue.5, pp.345-393, 1992.

C. Sternberg, Über Eine Eigenartige, Unter Dem Bilde Der Pseudoleukämie Verlaufende Tuberkulose Des Lymphatischen Apparates, Zeitschrift Für Heilkunde, vol.19, pp.21-90, 1898.

A. C. Stieber, O. Boillot, C. Scotti-foglieni, M. A. Nalesnik, R. D. Gordon et al., The Surgical Implications of the Posttransplant Lymphoproliferative Disorders, Transplantation Proceedings, vol.23, issue.1, pp.1477-79, 1991.

F. Suarez, O. Lortholary, O. Hermine, and M. Lecuit, InfectionAssociated Lymphomas Derived from Marginal Zone B Cells: A Model of AntigenDriven Lymphoproliferation, Blood, vol.107, issue.8, pp.3034-3078, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00022498

L. J. Swinnen, M. Leblanc, T. M. Grogan, L. I. Gordon, P. J. Stiff et al., Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder, Transplantation, vol.86, issue.2, pp.215-237, 2008.

G. Szakonyi, M. G. Klein, J. P. Hannan, K. A. Young, R. Z. Ma et al., Structure of the Epstein-Barr Virus Major Envelope Glycoprotein, Nature Structural & Molecular Biology, vol.13, issue.11, pp.996-1001, 2006.

G. S. Taylor, H. Jia, K. Harrington, L. W. Lee, J. Turner et al., A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, vol.20, pp.5009-5031, 2014.

G. Thé, N. E. De-, A. Day, M. F. Geser, J. H. Lavoué et al., Sero-Epidemiology of the Epstein-Barr Virus: Preliminary Analysis of an International Study-a Review, IARC Scientific Publications, vol.2, issue.11, pp.3-16, 1975.

R. Thomas, A. Kurt, C. Kallenborn, J. L. Wickenhauser, A. Schultze et al., Constitutive Expression of c-FLIP in Hodgkin and Reed-Sternberg Cells, The American Journal of Pathology, vol.160, issue.4, pp.62578-62581, 2002.

X. Troussard and M. Roussel, Syndrome Mononucléosique, 2005.

M. Vignais, Protéines JAK et STAT dans la transmission du signal cellulaire, 1997.

D. Vignon, Transfusion sanguine: une approche sécuritaire, 2000.

R. C. Walker, F. William, J. G. Marshall, R. H. Strickler, J. A. Wiesner et al., Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder, Clinical Infectious Diseases, vol.20, issue.5, pp.1346-53, 1995.

D. Wang, D. Liebowitz, and E. Kieff, An EBV Membrane Protein Expressed in Immortalized Lymphocytes Transforms Established Rodent Cells, Cell, vol.43, issue.3, pp.90256-90265, 1985.

X. Wang, W. J. Kenyon, Q. Li, J. Müllberg, and L. M. Hutt-fletcher, Epstein-Barr Virus Uses Different Complexes of Glycoproteins gH and gL to Infect B Lymphocytes and Epithelial Cells, Journal of Virology, vol.72, issue.7, pp.5552-58, 1998.

, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Reflects the Views of a Working Group That Convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), 2007.

M. A. Weniger, C. K. Melzner, S. Menz, A. J. Wegener, K. Bucur et al., Mutations of the Tumor Suppressor Gene SOCS-1 in Classical Hodgkin Lymphoma Are Frequent and Associated with Nuclear PhosphoSTAT5 Accumulation, Oncogene, vol.25, issue.18, pp.2679-84, 2006.

L. L. Williams, C. M. Rooney, M. E. Conley, M. K. Brenner, R. A. Krance et al., Correction of Duncan's Syndrome by Allogeneic Bone Marrow Transplantation, Lancet, vol.342, issue.8871, pp.587-88, 1993.

, World Bank Country and Lending Groups-World Bank Data Help Desk, 2016.

Y. T. Wu, H. L. Luo, and D. R. Johnson, Effect of Nickel Sulfate on Cellular Proliferation and Epstein-Barr Virus Antigen Expression in Lymphoblastoid Cell Lines, Cancer Letters, vol.32, issue.2, pp.171-79, 1986.

. Xiao, J. M. Jianqiao, R. Palefsky, S. M. Herrera, and . Tugizov, Characterization of the Epstein-Barr Virus Glycoprotein BMRF-2, Virology, vol.359, issue.2, pp.382-96, 2007.

L. S. Young and A. B. Rickinson, Epstein-Barr Virus: 40 Years on, Nature Reviews Cancer, vol.4, issue.10, pp.757-68, 2004.

M. C. Yu and J. Yuan, Epidemiology of Nasopharyngeal Carcinoma, Seminars in Cancer Biology, vol.12, issue.6, pp.421-450, 2002.

C. Zheng, Q. Yin, and H. Wu, Structural Studies of NF-?B Signaling, Cell Research, vol.21, issue.1, pp.183-95, 2011.

X. Zheng, L. Yan, B. Nilsson, G. Eklund, and B. Drettner, Epstein-Barr Virus Infection, Salted Fish and Nasopharyngeal Carcinoma. A Case-Control Study in Southern China, Acta Oncologica, vol.33, issue.8, pp.867-72, 1994.

B. Zhivotovsky, Caspases: The Enzymes of Death, Essays in Biochemistry, vol.39, pp.25-40, 2003.